TAMs can bind to vascular cell adhesion 1 on the surfaces of the cancer cells to enhance cancer cell survival and resistance to death signals (e.g., TRAIL) by activating PI3K/Akt pathway signaling. The gene discussed is AKT1; the disease is cancer.